Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
13.03
-1.92 (-12.84%)
At close: Apr 28, 2026, 4:00 PM EDT
13.05
+0.02 (0.15%)
After-hours: Apr 28, 2026, 5:40 PM EDT
Relay Therapeutics Employees
Relay Therapeutics had 192 employees as of December 31, 2025. The number of employees decreased by 69 or -26.44% compared to the previous year.
Employees
192
Change (1Y)
-69
Growth (1Y)
-26.44%
Revenue / Employee
$79,974
Profits / Employee
-$1,439,995
Market Cap
2.47B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Zai Lab | 1,784 |
| Ultragenyx Pharmaceutical | 1,371 |
| ADMA Biologics | 647 |
| Tarsus Pharmaceuticals | 370 |
| Vera Therapeutics | 249 |
| Celldex Therapeutics | 198 |
| Soleno Therapeutics | 182 |
| Immunome | 177 |
RLAY News
- 1 day ago - Relay Therapeutics Transcript: Study result - Transcripts
- 1 day ago - Relay Therapeutics Announces Clinical Data for Zovegalisib plus Atirmociclib Triplet Combination Supportive of Further Development in Frontline Metastatic Breast Cancer - GlobeNewsWire
- 26 days ago - Relay Therapeutics to Present Initial Clinical Data on Zovegalisib in Vascular Anomalies at the International Society for the Study of Vascular Anomalies World Congress 2026 - GlobeNewsWire
- 6 weeks ago - Relay Therapeutics' Cancer Drug Hits 11.1-Month Progression Free Survival - What Does This Means For Pretreated Breast Cancer Patients? - Benzinga
- 6 weeks ago - Relay Therapeutics Announces Data from Zovegalisib + Fulvestrant at the Phase 3 Dose of 400mg BID Fed at ESMO Targeted Anticancer Therapies Congress 2026 - GlobeNewsWire
- 6 weeks ago - Relay Therapeutics Transcript: Barclays 28th Annual Global Healthcare Conference - Transcripts
- 2 months ago - Relay Therapeutics Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Relay Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Outlines Anticipated 2026 Milestones - GlobeNewsWire